The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Hendrik Ungefroren; Björn Konukiewitz; Ulrich F. Wellner; Jörg Schrader; Tobias Keck

doi:10.3390/cancers15010160

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Hendrik Ungefroren^*, Björn Konukiewitz, Ulrich F. Wellner, Jörg Schrader, Tobias Keck

^*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

Originalsprache	Englisch
Aufsatznummer	160
Zeitschrift	Cancers
Jahrgang	15
Ausgabenummer	1
ISSN	2072-6694
DOIs	https://doi.org/10.3390/cancers15010160
Publikationsstatus	Veröffentlicht - 01.2023

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Profilbereich: Lübeck Integrated Oncology Network (LION)
Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)
Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

DFG-Fachsystematik

2.22-25 Allgemein- und Viszeralchirurgie
2.22-14 Hämatologie, Onkologie
2.22-17 Endokrinologie, Diabetologie, Metabolismus

Dokumente

10.3390/cancers15010160

Weitere Links

Zitieren

@article{fcdc2d8b29b441f3b67c945b118f65c3,

title = "The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses",

abstract = "Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5\% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].",

author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and Wellner, \{Ulrich F.\} and J{\"o}rg Schrader and Tobias Keck",

year = "2023",

month = jan,

doi = "10.3390/cancers15010160",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

number = "1",

}

TY - JOUR

T1 - The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Wellner, Ulrich F.

AU - Schrader, Jörg

AU - Keck, Tobias

PY - 2023/1

Y1 - 2023/1

N2 - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

AB - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

UR - https://www.scopus.com/pages/publications/85145929498

UR - https://www.mendeley.com/catalogue/2ce1912b-273c-3782-8b94-fc263b509628/

U2 - 10.3390/cancers15010160

DO - 10.3390/cancers15010160

M3 - Editorial

C2 - 36612156

AN - SCOPUS:85145929498

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 1

M1 - 160

ER -

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

DFG-Fachsystematik

Dokumente

Weitere Links

Fingerprint

Zitieren